CTL-ADV

Adenovirus-specific T cell therapy · Central Hospital, Nancy, France

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTL-ADV, covering 2016-09-15 to 2016-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) [Phase 1, Phase 2]

See pricing